A century ago, type 1 diabetes was a death sentence. Children diagnosed rarely survived more than a year or two, wasting away as their bodies starved despite food. Then, in 1921, in a modest lab in ...

Eli Lilly sells one of the most sought-after types of drugs today: weight loss drugs. The company’s Zepbound and Mounjaro have brought in blockbuster revenue, and more growth could be on the horizon.

Eli Lilly (NYSE: LLY) soared more than 60% from the start of the year through its peak this summer, thanks to the company's dominance in one of today's most in-demand areas: the obesity drug market.

Dr. Nora Volkow, who leads the National Institutes of Drug Abuse, would like the public to know things are getting better. Mostly. By Matt Richtel Historically speaking, it’s not a bad time to be the ...

Pharmaceutical company Eli Lilly is warning that two of its insulin offerings for diabetic patients will be temporarily out of stock through the beginning of April. The drug maker released a statement ...

Both generic and branded formulations of 10-mL vials of insulin lispro injection (Humalog) will be temporarily out of stock through the start of April, Eli Lilly announced. A new study predicted ...

Consumers who are struggling to get discounted insulin due to pharmacy restrictions and red tape will soon have another option to order the life-saving medication needed by millions of people. Amazon ...

Add Yahoo as a preferred source to see more of our stories on Google. Consumers who are struggling to get discounted insulin due to pharmacy restrictions and red tape will soon have another option to ...

Shares of Indianapolis-based Eli Lilly and Co. soared to an all-time high Tuesday morning after the company reported that its new diabetes drug Mounjaro pulled in nearly $1 billion in the second ...

(Reuters) - Americans without health insurance pay an average of $98 for Eli Lilly’s generic insulin despite the company’s May 1 pledge to cut its list price to $25 per vial, according to a survey of ...

Sen. Bernie Sanders’s prepared remarks at the opening of the Senate Health, Education, Labor, and Pensions Committee’s hearing titled “The Need to Make Insulin Affordable for All Americans.” First, ...

PITTSBURGH — Relief is coming for some diabetics in the area paying high prices for insulin. It’s an issue Channel 11 has covered for years. We even followed a group of Western Pennsylvanians to ...